 |
Previous Article | Next Article 
The Journal of Neuroscience, November 15, 1998, 18(22):9376-9385
Schwann Cells Proliferate at Rat Neuromuscular Junctions during
Development and Regeneration
Flora M.
Love and
Wesley J.
Thompson
Department of Zoology, University of Texas at Austin, Austin, Texas
78712
 |
ABSTRACT |
Terminal Schwann cells (TSCs) cover neuromuscular junctions and are
important in the repair and maintenance of these synapses. We have
examined how these cells are generated at developing junctions and how
their number is regulated during repair of nerve injury. At birth,
approximately half of the junctions in rat soleus and extensor
digitorum longus muscles have one TSC soma. Somata are absent from the
remainder, although Schwann cell (SC) processes arising from somata
along the preterminal axon cover almost all of these synapses. By 2 months of age, junctions have gained an additional two to three TSCs.
Most of this gain occurs during the first 2 postnatal weeks and largely
precedes the expansion of endplate size. Although the initial addition
is caused by cell migration, mitotic labeling shows extensive division
of TSCs at junctions. A slower addition of TSCs occurs in adult
muscles, and TSC number in the adult is correlated with endplate size.
During repair of nerve injury, TSC number is regulated by a combination
of signals from motor neurons and denervated tissue. As shown
previously (Connor et al., 1987 ), denervation of adult muscles did not,
in itself, cause TSC mitosis. However, TSCs became mitotic during
reinnervation. Partial denervation induced division of TSCs at
innervated but not denervated endplates. A disproportionate number of
these mitotic cells were found at endplates contacted by TSC processes
extended from nearby denervated endplates, contacts known to promote
nerve sprouting. These results show an association between TSC mitotic
activity and alterations in synaptic structure during development,
sprouting, and reinnervation.
Key words:
Schwann cell; proliferation; mitosis; migration; cell
number; neuromuscular junction; development; partial denervation; reinnervation; denervation; sprouting; endplate area
 |
INTRODUCTION |
Schwann cells cover the terminal
arborizations of motor axons at neuromuscular junctions. These
"terminal" Schwann cells (TSCs) are important in the repair of
synapses after nerve injury. At the time of muscle denervation, TSCs
extend processes that guide regenerating axons (Son and Thompson,
1995a ). In partially denervated muscles, TSC processes extend from
denervated synaptic sites and grow to nearby innervated synaptic sites.
These TSC "bridges" induce nerve terminals to grow or "sprout"
and guide these sprouts to the denervated synaptic sites (Son and
Thompson, 1995b ).
Several observations suggest that TSCs also function in the normal
maintenance of neuromuscular junctions. TSCs are known to sense
synaptic activity at neuromuscular junctions. These cells possess
muscarinic and purinergic receptors that bind acetylcholine and ATP,
respectively, released by the nerve terminals (Robitaille, 1995 ;
Robitaille et al., 1997 ). As a consequence of the second messengers
induced by binding of acetylcholine to the muscarinic receptors and the
action of these messengers on internal calcium stores, synaptic
activity results in an elevation of intracellular calcium in TSCs
(Jahromi et al., 1992 ). These activity-induced calcium fluctuations
appear to regulate the expression of certain genes: blockade of neural
activity or of transmitter release evokes expression of the gene for
glial fibrillary acidic protein, a protein that may be important in TSC
process extension (Georgiou et al., 1994 ). In addition to their ability
to sense and respond to changes in synaptic activity, TSCs also have
the capacity to alter the structure of neuromuscular synapses.
Processes growing from SCs implanted into the endplate zone of normal
muscle, on contacting the endplates in the host muscle, alter the area
of contact between the nerve terminal and muscle fiber (Trachtenberg and Thompson, 1997 ).
In view of the influence that TSCs can exert on motor axons and
neuromuscular junctions, we undertook a study to determine how the
number of these cells at neuromuscular junctions is regulated. We
extend previous observations of SC addition to developing junctions (Love and Thompson, 1996 ; Hirata et al., 1997 ), relate TSC number to
junctional size, describe SC mitosis at developing junctions, and
report on the mitotic response of SCs in adult junctions to denervation, reinnervation, and partial denervation. These results show
that there is a dynamic relationship between TSCs and motor neuron
terminals during development, reinnervation, and sprouting.
 |
MATERIALS AND METHODS |
Animals and surgery
Developmental study. The soleus and extensor
digitorum longus (edl) muscles were examined in Wistar rats at
postnatal day 0 (P0), P7, and P14, in adults (2 months of age), and in
older adults (15-17 months). Muscles were removed under deep ether
anesthesia and immersed in oxygenated Ringer's solution (Liley,
1956 ).
Reinnervation. Animals were anesthetized by intraperitoneal
injections of ketamine/xylazine. The soleus nerve was crushed 1 mm from
entry into the soleus muscle in 5- to 6-week-old Wistar rats. The
soleus muscles were examined 6-8 d later. Results were compared with
those obtained in a separate set of animals in which the soleus was
fully denervated for an equivalent period of time.
Partial denervation. The AO strain of Wistar rats in which
innervation of the soleus is often derived from two separate nerves (Thompson and Jansen, 1977 ) was used. Partial denervation was accomplished by resecting one of the two nerves (the soleus nerve at
the entry point into the muscle) in 5-week-old rats.
Bromodeoxyuridine administration
Bromodeoxyuridine (BrdU) (203806; Calbiochem, La Jolla, CA)
dissolved in 0.9% NaCl containing 0.007N NaOH was injected into the
peritoneal cavity. A dose of 1 mg/10 gm of body weight was administered
to adults receiving multiple injections and to neonates. In adults
receiving a single injection, 2 mg/10 gm of body weight was given.
Whole-mount immunolabeling
After removal from the animal, the soleus and edl muscles were
fixed in 4% paraformaldehyde. For ages P7 to adult, muscles were fixed
for 10 min. For P0 and BrdU-treated animals, the time was extended to
20 min to allow for better fixation of S-100. Muscles were then rinsed
for 30 min in three changes of 0.1 M PBS, pH 7.4, permeabilized in 20°C methanol for 5-10 min (depending on the size
of the muscle), washed again in PBS for 30 min, and blocked in PBS
containing 0.3% Triton X-100, 0.2% bovine serum albumin, and 0.1%
sodium azide. In BrdU-treated animals, before blocking, muscles were
denatured in 2N HCl in PBS containing 0.3% Triton X-100 for 30 min and
subsequently washed for 30 min in three changes of PBS containing
Triton X-100. Muscles were then incubated in primary antibodies
overnight at room temperature. The following antibodies were used. SCs
were labeled with rabbit anti-cow S-100 (Dako, Carpinteria, CA),
diluted 1: 500; axons were labeled with mouse monoclonal antibodies to
a neurofilament protein (2H3 supernatant, Developmental Studies
Hybridoma Bank), diluted 1:250; and nerve terminals were labeled with
mouse monoclonal antibodies to synaptophysin (Sigma, S-5768; Sigma, St.
Louis, MO), diluted 1:400. Cells that incorporated BrdU were labeled with a 1:5 dilution of mouse monoclonal antibodies to BrdU (G3G4 supernatant, Developmental Studies Hybridoma Bank). Proliferating cells
were also labeled with mouse monoclonal antibodies to proliferating cell nuclear antigen (PCNA), diluted 1:1000 (Sigma, P-8835). In nerve
injury studies, denervated endplates were identified by labeling with
Cy5-conjugated bungarotoxin. After incubation in primary antibodies,
muscles were rinsed in three changes of PBS for 30 min and incubated in
secondary antibodies for 1 hr at room temperature. The secondary for
S-100 was rhodamine-conjugated goat F(ab)2 fragment
anti-rabbit (Cappel, 55671), diluted 1:400. The secondary for the
anti-synaptophysin, anti-neurofilament, BrdU, and PCNA antibodies was
fluorescein-conjugated sheep F(ab')2 fragment anti-mouse
(Sigma, F-2266), diluted 1:100. After incubation with the secondary
antibodies, the muscles were rinsed in PBS for 30 min. Nuclei were then
stained by placing the muscles in PBS containing
4',6-diamidino-2-phenylindole (DAPI) (10 4
mg/ml) for 7 min.
After immunostaining, thin layers of the muscles were dissected and
mounted in fluorescence mounting medium [formula of Johnson and de C
Nogueira Araujo (1981) , with 0.1 M ethanolamine substituted for PBS and PPD increased to 2 mg/ml]. The final pH of the solution was 9.5 (Swartz and Santi, 1996 ). The tissue was then examined using a
Nikon microscope equipped for epifluorescence. Images were acquired
using rhodamine, fluorescein, UV, and Cy5 filters and an integrating
CCD camera connected to a Macintosh computer equipped with a frame
grabber and running NIH Image software.
Analysis
The number and position of TSC nuclei were determined by the
colocalization of labels for DAPI and S-100 over synaptophysin-labeled nerve terminals. Endplates in an en face orientation within
the endplate zone were examined. A minimum of 30 endplates was examined from each animal. Although mitosis of SCs was observed on preterminal axons and in the intramuscular nerves, quantification was not possible
because only short segments of axons were visible.
Measurements of the nerve terminal area were made in adult animals only
at endplates at which there was no SC soma on the preterminal axon. In
this manner, we eliminated the ambiguity of whether these cells should
be counted in the TSC number because their processes could contribute
to the coverage of the endplate. Areas were determined from digitized
images by the use of NIH Image software running on a Macintosh
computer. The gray scale image of the synaptophysin-labeled nerve
terminal was converted to binary, and the threshold was adjusted for
black/white to obtain a black image that by visual inspection
encompassed the nerve terminal. The area of the black pixels was then
determined by the software.
Proliferation of SCs at the neuromuscular junction was examined by
counting the number of TSCs that incorporated BrdU or were labeled with
antibodies to PCNA (see above). It has been reported that in tissues
fixed with aldehydes, PCNA labeling occurs throughout the cell cycle,
whereas in tissues fixed with organic solvents, staining occurs only
during DNA synthesis (Bravo and Macdonald-Bravo, 1987 ).
Paraformaldehyde was necessary for fixation of the SC antigen S-100 but
may have resulted in labeling of PCNA in the absence of replication. To
verify that the PCNA staining occurred only in proliferating cells,
tissues were fixed with methanol instead of paraformaldehyde, and the
number of PCNA-labeled nuclei positioned directly over the nerve
terminals was compared with the number of TSCs labeled with PCNA in
paraformaldehyde-fixed muscles. Both soleus and edl muscles were
removed from one P10 rat. In the soleus and edl muscle fixed with
paraformaldehyde, 18% (12/67) and 23% (26/113), respectively, of the
endplates had a cell that labeled with both PCNA and S-100. In the
soleus and edl muscle fixed with methanol, 26% (23/89) and 22%
(30/136), respectively, of the endplates had PCNA-labeled cells
overlying the nerve terminals. Thus, there were no more nuclei labeled
in the paraformaldehyde-fixed muscles than in the methanol-fixed muscles.
 |
RESULTS |
The number of SC somata at the endplate increases during
postnatal development and differs between soleus and edl
To examine developmental changes in the number of TSCs, rat soleus
and edl muscles of various ages were triple-labeled with rabbit
polyclonal antibodies identifying SCs (anti-S-100), a combination of
two mouse monoclonal antibodies (anti-neurofilament and
anti-synaptophysin) identifying axons and nerve terminals, and a
nuclear label (DAPI). By the use of rhodamine- and
fluorescein-conjugated secondary antibodies to rabbit and mouse
antibodies and by examination with appropriate filters for DAPI,
fluorescein, and rhodamine, individual synapses and the SCs covering
them could be identified (Figs. 1, 2).
Comparison of the SC and nuclear labels allowed a determination of the
number of SC somata present. At the time of birth, many endplates in
soleus and edl (Fig. 1) had no SC somata. Counting only somata present
at the endplate, an average of 0.44 ± 0.12 SCs (range, 0-2; 104 endplates examined) were present at endplates in the newborn soleus,
and 0.69 ± 0.09 (range 0-2; 96 endplates examined) were present
in edl. Most (99/102 = 97%) of those endplates lacking SC somata
were covered by SC processes arising from a soma or somata located
along the preterminal axon (Fig. 1).

View larger version (112K):
[in this window]
[in a new window]
|
Figure 1.
Image of an edl endplate at P0. At P0,
approximately half of the endplates in soleus and edl have no SC
somata. A, SCs labeled with anti-S-100 antibodies;
B, preterminal axons (arrow) labeled with
anti-neurofilament antibodies (NF), and nerve
terminal (arrowhead) labeled with anti-synaptophysin
(SYN) antibodies; C, nuclei
labeled with DAPI. Several preterminal axons enter the
endplate (B), showing the polyneuronal
innervation present at this age. Despite the presence of SC processes
covering the terminal, no SC somata are present at the junction.
Rather, two SC somata (asterisks) are located on the
preterminal axons. DAPI and S-100 images were taken in the same focal
plane. Other nuclei, oriented horizontally, are likely to be muscle
nuclei. Scale bar, 10 µm.
|
|
Applying this same analysis to adult junctions (animals at 2 months of
age) revealed that, on average, 2.7 ± 0.3 (range 1-7; 182 endplates examined) nuclei were present at junctions in soleus and
3.7 ± 0.2 (range 1-9; 248 endplates examined) were present in
edl. Thus, in agreement with a previous report (Hirata et al., 1997 ),
SCs are added to junctions during postnatal development. The most
dramatic increase in TSC number occurs during the first 2 weeks of
postnatal life (Fig. 2G). In
soleus, the number of TSCs increased 384% from P0 to P14 but only 25%
from P14 to 2 months of age. In edl, TSC number increased 272% from P0
to P14, but only 43% from P14 to 2 months of age. Examination of
muscles at 15 months of age suggests that addition of TSCs continues
even in the adult, but at a much slower pace than that seen during the
first 2 months of age. Muscles at 15 months have gained one to two
additional TSCs over those present at 2 months of age.

View larger version (40K):
[in this window]
[in a new window]
|
Figure 2.
The number of TSC somata increases during
postnatal development and adulthood. Image of one edl endplate at P7
(A-C) and one at 2 months
(D-F). A, D, TSCs labeled with
anti-S-100 antibodies; B, E, preterminal axon and nerve
terminal, labeled with anti-neurofilament and anti-synaptophysin
antibodies; C, F, nuclei labeled with DAPI.
Asterisks mark the nuclei of cells that colabel with
S-100. This P7 endplate has one TSC soma compared with five TSC somata
at the adult endplate. Scale bars, 10 µm. G, Line
graph of TSC number at P0, P7, P14, 2 months, and15-17 months in soleus. The number of TSCs was determined
by colocalizing DAPI and S-100 labels over synaptophysin-labeled
regions. Three rats from each age group were examined, and a minimum of
30 endplates was examined in each muscle. An ANOVA for the change in
TSC number with age was significant for both soleus and edl
(p < 0.005).
|
|
TSC number is correlated with terminal area, but most of the gain
in TSC number precedes the gain in endplate area
One possible explanation of the increase in TSC number with
development is the growth in the size of endplates with age as muscle
fibers expand in diameter (cf. Balice-Gordon et al., 1990 ). To examine
the correlation between endplate area and TSC number, endplate area
(measured as the terminal arborization labeled with anti-synaptophysin
antibody) and TSC numbers were determined for junctions in muscles from
2-month-old adults. There was a tendency for larger endplates to have
more SCs, both in soleus and edl (Fig.
3A). The correlation
coefficient (r) for TSC number and endplate size was 0.37 for soleus and 0.68 for edl. Both numbers are significantly different
(p < 0.01) from what would be expected for a
random relationship between area and TSC number. However, the
proportion of the variation in TSC number that can be accounted for by
endplate area (the square of the correlation coefficient) is only 14%
for soleus and 46% for edl.

View larger version (33K):
[in this window]
[in a new window]
|
Figure 3.
TSC number is correlated with terminal area, but
most of the postnatal gain in TSC number precedes the gain in endplate
area. A, Correlation of nerve terminal area and TSC
number in 2-month-old soleus and edl muscles. The correlation
coefficient (r) was 0.37 for soleus and 0.68 for
edl. R2 = 0.14 for soleus and 0.46 for edl. Both are significant with p < 0.01. Nerve
terminal area was determined by measuring the area labeled by
anti-synaptophysin antibodies. TSC number was determined by
colocalization of S-100 and DAPI labeling over the nerve terminal
region. B, Change in TSC number (solid
line) and endplate area (hatched line) with age
in soleus and edl. Data for the change in TSC number with age in soleus
are replotted from Figure 2G. Endplate area was
determined by measuring the area labeled by binding of
rhodamine-conjugated -bungarotoxin in one set of muscles. The number
of TSCs was determined in a second set of muscles by colocalization of
DAPI and S-100 labels over synaptophysin-labeled regions. In each set
of muscles, three rats from each age group were examined, and a minimum
of 30 endplates was examined in each muscle.
|
|
Additional observations of the relationship between endplate area and
TSC number were made in animals during postnatal development, a time in
which there is a dramatic increase in the endplate area (cf. Slater,
1982 ; Balice-Gordon and Lichtman, 1990 ; Waerhaug, 1992 ). As reported
above, most of the addition of TSCs occurs in the first 2 postnatal
weeks. Likewise, endplate area increases by approximately fourfold from
birth to adulthood; however, most of this increase occurs after P14
(Fig. 3B). Thus, the increase in endplate area lags behind
the increase in TSC number. In soleus, for example, there is a fourfold
increase in TSC number during the period from birth to P14 when the
endplate area increases less than twofold. Between P14 and P60, the
endplate area increases by more than twofold, but the TSC number
increases only 25%. Therefore, expanding endplate area may not be the
major change driving the increase in TSC number.
Migration and mitosis account for the addition of SCs to
developing junctions
As stated above, ~30-55% of the endplates in edl and soleus
have no TSCs at the time of birth. Thus, the initial increase cannot
occur by mitosis of SCs at the endplate. Two other possibilities exist.
(1) SCs may migrate into the endplate along preterminal axons, or (2)
TSCs may differentiate from S-100-negative precursor cells located at
the endplate. This latter possibility, however, is not likely given
that many newborn junctions lack any nuclei overlying the nerve
terminal (compare Fig. 1). It appears, therefore, that some of the SCs
located along the preterminal axons that extend processes to cover the
endplate migrate into the endplate subsequent to the time of birth.
Such migration could account for all of the TSCs present at junctions.
Alternatively, division of TSCs at the junction could contribute to the
rise in number. Therefore, an attempt was made to determine whether
TSCs underwent mitoses at developing junctions. Preliminary experiments
were performed in which the mitotic label BrdU was injected one to
three times, 90 min apart, in two P10 rats, and the muscles were
removed 9 hr after the first injection. BrdU-positive nuclei that were
also S-100-positive were present at 10% (40 of 398) of the endplates
in soleus and 14% (43 of 305) of those in edl. Most of these endplates
had only a single labeled nucleus. However, 12 of the 40 endplates in
soleus and 16 of the 43 in edl had two labeled nuclei in close
apposition, suggesting that these were daughter cells that had
completed mitosis. The small number of nuclear pairs is not surprising
considering that only 9 hr had elapsed since the first BrdU injection
and because estimates of the length of G2 + M
(the time between the end of synthesis and the end of mitosis) for SCs
in the peripheral nerves of mice is ~4-8 hr (Asbury, 1967 ; Usson and
Saxod, 1988 ). Thus, only those cells that were in the late phase of DNA
synthesis at the time of the BrdU injection would have completed
mitosis. These observations show that mitosis contributes to the rise
in SC number at developing endplates. Although the presence of pairs of
labeled TSC nuclei at single endplates 9 hr after injection of BrdU
suggests that TSCs may undergo mitosis at the endplate, it is difficult
to exclude the possibility that the labeled cells divided somewhere
along the nerves and then migrated into the endplate. Similarly, it is
difficult to argue that a single labeled nucleus at the endplate
indicates DNA synthesis at this site, because only one of the daughters
of cells completing mitosis may have migrated into the endplate.
To determine where SCs that come to cover the nerve terminal divide, a
more quantitative analysis was made after a single injection of BrdU
into three P8 animals, 30 min before they were killed. Our
reasoning was that this would be an insufficient time (given the
interval for G2 + M) for cells to complete
mitosis and migrate into the junctions. In three animals, 4, 5, and 6% (average, 5%; 488 endplates examined) of the endplates in soleus and
6, 9, and 10% (average, 8%; 198 endplates examined) in edl had a TSC
labeled by BrdU (Fig. 4). No BrdU-labeled
cells were encountered after a similar 30 min labeling in muscles at 5 weeks (n = 3).

View larger version (62K):
[in this window]
[in a new window]
|
Figure 4.
Image of a TSC at a P8 soleus endplate labeled
with BrdU. SCs divide at the neuromuscular junction during early
postnatal development. A, TSC, labeled with antibodies
to S-100; B, preterminal axon (a)
labeled with anti-neurofilament antibodies, SC nucleus
(b) labeled with antibodies to BrdU, nerve
terminal (c) labeled with anti-synaptophysin
antibodies; C, SC nucleus labeled with DAPI. The BrdU
antibodies and the antibodies used to detect axons and nerve terminals
were all mouse monoclonals. Thus, mitotic nuclei, axons, and terminals
were labeled using the same FITC-conjugated secondary antibody.
Although the endplate in B is labeled with three primary
antibodies, the BrdU-labeled nucleus (arrow b) is easily
distinguished from the nerve terminal and the preterminal axon. Scale
bar, 10 µm.
|
|
The numbers of TSCs labeled by a 30 min exposure to BrdU appear quite
reasonable given our earlier determination of the numbers of SCs added
to junctions. From simply counting SCs at junctions, we determined that
~0.14 SCs are added each day to each junction in soleus and 0.11 in
edl. Assuming that TSCs, like their counterparts in the nerve, have an
8 hr DNA synthesis period and a 24 hr cell cycle (Asbury, 1967 ),
one-third (i.e., 8/24) of these cells should be undergoing DNA
synthesis at any moment in time and would be expected to be labeled by
injections of BrdU over a 30 min period. This leads to the prediction
that 4.7% (0.14/3) of the TSCs should incorporate BrdU in soleus and
3.7% in edl. Thus, the observed labeling is reasonably consistent with
that anticipated if mitosis at the junction accounts for most of the
addition of SCs to junctions.
To verify the results obtained using BrdU, muscles were also labeled
with antibodies to PCNA, an auxiliary protein of DNA polymerase whose
expression in the nucleus increases during DNA synthesis (Bravo and
Macdonald-Bravo, 1987 ). Labeling of TSCs was seen at all of the early
postnatal ages examined (P0, P7, P8, and P10). A quantitative analysis
was performed at P10 in one rat. In soleus, 17% (12 of 69) of the
endplates had a TSC labeled with PCNA. In edl, 22% (30 of 136) of the
endplates had a PCNA-labeled TSC. In cells fixed with paraformaldehyde,
staining can occur throughout the cell cycle and is present in the
cytoplasm for ~24 hr after mitosis (Bravo and Macdonald-Bravo, 1987 ).
Thus, it is not surprising that more cells were labeled by PCNA than by
a single injection of BrdU. Furthermore, some of the PCNA-labeled cells
may represent those that divided on the nerve and subsequently migrated to the endplate. No PCNA labeling of TSCs was observed in
muscles at 3 months of age (n = 3).
In transiently denervated muscles, TSCs divide, not in response to
denervation but during reinnervation
TSCs appear to play important roles in the repair of nerve damage
and the reinnervation of muscle fibers. Therefore, we wished to know
whether proliferation of these cells accompanied muscle denervation and
reinnervation. For this purpose, the soleus muscle was denervated by
nerve crush or resection in 5- to 6-week-old rats. At 6 d after
nerve crush, axon terminals had returned to all the junctions. In
contrast, no reinnervation was observed in muscles in which a piece of
the nerve was resected, even 8 d after resection. At 6, 7, and
8 d after crush or resection, animals received a single injection
of BrdU 30 min before they were killed. In muscles that were
denervated, no BrdU-positive TSCs were seen in a total of 386 endplates
examined (three animals). Thus, denervation per se did not promote SC
mitosis at junctions. In contrast, all three animals that were
being reinnervated after nerve crush had BrdU-positive TSCs (Fig.
5). On average, 16 ± 5% (365 endplates examined) had at least one BrdU-labeled TSC. Because
only 30 min had elapsed after the BrdU injection, it is unlikely that
these cells had migrated into the junctions; rather, it appears that
they became mitotic on the junction itself.

View larger version (71K):
[in this window]
[in a new window]
|
Figure 5.
Image of a TSC labeled with BrdU at a reinnervated
endplate 7 d after nerve crush. Proliferation of TSCs occurs
during reinnervation after nerve injury. A, SCs labeled
with anti-S-100 antibodies; B, mitotic cells are labeled
with antibodies to BrdU, and the preterminal axon
(a) and nerve terminal (b)
are labeled with anti-neurofilament and anti-synaptophysin antibodies;
C, nuclei labeled with DAPI. A TSC that labels with BrdU
is indicated by the arrowhead present in each panel. An
additional BrdU-labeled nucleus can be seen adjacent to the endplate
that does not belong to a TSC (compare A, B). Scale bar,
10 µm.
|
|
Antibodies to PCNA were also used to identify mitotic cells in
denervated and reinnervated muscles. In two animals, 6 d after soleus nerve crush, 28% (22 of 77) and 40% (29 of 72) of reinnervated endplates had at least one PCNA-positive TSC. In contrast, none of the
165 endplates examined in two muscles denervated by nerve resection for
6 d had PCNA-labeled TSCs. As in the neonates, the percentages of
cells labeled with PCNA are higher than with BrdU and may reflect the
presence of detectable levels of PCNA beyond the period of DNA synthesis.
After partial denervation, SCs proliferate at innervated
endplates, particularly those connected to denervated endplates by SC
bridges
TSCs play a major role in the nerve sprouting that follows damage
to a portion of the axon supply to the muscle, i.e., in response to
partial denervation. A great deal of the growth of nerve sprouts occurs
along processes extended from TSCs at denervated endplates that come
into contact with innervated endplates, i.e., along SC bridges (Son and
Thompson, 1995b ). To examine how partial denervation affects TSC
mitotic activity, one of two nerves supplying the soleus was resected
so that only a few of the motor axons to the muscle remained. In a
preliminary set of experiments using two 5-week-old rats, BrdU was
injected at multiple times on each of the 3 d after partial
denervation. When the soleus muscles were examined on the fourth day,
BrdU-labeled SCs were found at 18 of 67 innervated endplates and 2 of
128 denervated endplates. These two examples at denervated endplates,
however, represented a special case. They were connected to innervated
endplates by a SC bridge, resulting in their reinnervation by terminal
sprouts. In addition, 12 of the 18 innervated endplates with mitotic
TSCs were connected to adjacent denervated synaptic sites by a SC
bridge. In total, there were 22 pairs of endplates connected by
bridges. Of these, 12 had a BrdU-labeled SC on the innervated endplate, two had BrdU-labeled SCs located on the bridge linking the two endplates, and two had a mitotic SC on the denervated endplate. These
results suggest that TSC proliferation is a consequence of partial
denervation and in most cases is associated with bridge formation.
Given the long-term presence of BrdU and the possibility of SC
migration, these experiments did not unambiguously identify the site
where SCs became mitotic.
To examine where SCs divide in partially denervated muscles, partial
denervations were performed on soleus muscles in six 5-week-old
animals. A single BrdU injection was given 3 d later, 30 min
before the animals were killed. BrdU-labeled TSCs were found at 62 of
494 innervated endplates but were absent from all denervated endplates
examined (1352). Because SC mitosis was not found in control muscles at
5 weeks of age (see above), it appears that the denervated fibers (or,
alternatively, denervated SCs or degenerating axons) in these partially
denervated muscles promote mitosis of those TSCs that remain in contact
with the nerve. Closer examination of the innervated endplates showing
SC mitosis revealed that many of these endplates were linked by SC
processes to nearby denervated endplates. In total, regardless of
mitotic state, 95 innervated endplates in these muscles had been
bridged to an adjacent denervated endplate by SC processes; nerve
sprouts were present on all of these bridges. Of these 95 pairs of
endplates, 29 had BrdU-labeled TSCs at the innervated endplate (Table
1, Fig. 6). Thus, 47% (29/62) of the labeled TSCs were found at 19% (95/494) of
the innervated endplates that had received this SC contact or bridge.
Thus, a disproportionate share of the mitotic TSC population is present
at these special endplates. In contrast, there were no BrdU-labeled
TSCs on the bridge linking the endplates or on the denervated endplates
connected to an innervated endplate by a SC bridge. This result
suggests that SCs growing from denervated synaptic sites can stimulate,
by contact, mitosis of the SCs at innervated endplates either directly
or indirectly by the induction of nerve terminal sprouting. Of the
innervated endplates that had mitotic TSCs but were not connected to
denervated endplates by SC bridges, many, but not all, were sprouting.
Another possibility is that the mitotic activity in these SCs (and the
other SCs not contacted by a bridge) is attributable to proximity to a
denervated muscle fiber or a denervated synaptic site. If so, this
explanation would require the frequency of bridges to be a function of
proximity of denervated and innervated synaptic sites. Because of the
way the muscles were prepared for examination in this study (as thin layers of fibers cut from the muscle that were then flattened), the
spatial interrelationships in the original muscle could not be
determined.
View this table:
[in this window]
[in a new window]
|
Table 1.
Mitotic TSCs in six rat soleus muscles partially denervated
for 3 d and injected with BrdU 30 min before rats were killed
|
|

View larger version (67K):
[in this window]
[in a new window]
|
Figure 6.
Image of a case of terminal sprouting in a soleus
muscle 3 d after partial denervation. After partial denervation,
SCs proliferate at innervated endplates, especially those connected to
denervated endplates by SC bridges. A, SCs labeled with
anti-S-100 antibodies; B, mitotic cells labeled with
antibodies to BrdU; preterminal axon and nerve terminal are labeled
with anti-neurofilament and anti-synaptophysin antibodies.
C, Nuclei labeled with DAPI. The muscle was also labeled
with Cy5-conjugated bungarotoxin (data not shown), allowing
identification of denervated endplates. Note that the innervated
endplate (a) is connectedby a terminal sprout (b) and the
associated SC bridge to an endplate that was denervated
(c), resulting in its reinnervation. A TSC
located at the innervated endplate is labeled with BrdU
(arrowheads). Scale bar, 10 µm.
|
|
 |
DISCUSSION |
TSCs appear to be important in the reinnervation of neuromuscular
junctions after nerve damage (Son and Thompson, 1995a ,b ). Moreover,
reactive SCs, i.e., SCs responding to the loss of nerve contact, can
produce major alterations in the structure of the adult neuromuscular
synapse (Trachtenberg and Thompson, 1997 ). Knowledge of when these
cells appear at junctions during development and how they respond to
nerve injury is therefore important for understanding the formation and
maintenance of this synapse. We have investigated changes in the SC
coverings of the nerve terminal at neuromuscular synapses during
development and regeneration. We find that these cells undergo mitosis
during early development, during muscle reinnervation, and during nerve
sprouting after partial denervation. Muscle denervation appears to
provide a stimulus for division, but this stimulus is only effective
when the SCs are in contact with an axon. This implies that the nerve
supplies some signal required for TSC division. Furthermore, this
stimulus for mitosis is greatly amplified by the contact of the nerve
terminal with reactive SC processes from denervated endplates.
Addition of TSCs during development
TSCs extend processes after complete and partial denervation that
appear to guide the growth of axons during reinnervation and sprouting
(Son and Thompson, 1995a ,b ). Whether SCs play a similar guidance role
during development has been a subject of some controversy (Keynes,
1987 ). Numerous investigators have used electron microscopy to examine
the morphology of developing neuromuscular junctions. In mammals, the
processes of SCs are present at junctions as they form in the embryo
(Kelly and Zacks, 1969 ). However, SCs appear to be absent from some
nascent junctions in birds (Jacob and Lentz, 1979 ) and
Xenopus (Kullberg et al., 1977 ). Studies that have examined
the role of SCs in axon guidance during embryonic development have also
produced conflicting results (Harrison, 1924 ; Yntema, 1943 ; Noakes and
Bennett, 1987 ; Dahm and Landmesser, 1988 ). The more recent use of mouse
mutants (Grim et al., 1992 ) and mouse knock-outs (Reithmacher et al.,
1997 ) that delete SCs strongly suggests that SCs are not needed for the
initial navigation of axons into the periphery or perhaps even for
initial formation of neuromuscular junctions. However, SCs do play an
important role in the maintenance of axons in early postnatal
development in that motor neurons die in mice lacking SCs (Reithmacher
et al., 1997 ).
In our study, SCs or SC processes, identified by immunohistochemistry
for the SC marker S-100, were found to be present at 99% (197/200) of
the neuromuscular junctions in two hindlimb muscles of the newborn rat.
It is not clear why 1% were devoid of TSC processes. One possible
explanation may be variations in the penetrance of the antibodies to
S-100. This possibility seems unlikely, however, considering that the
preterminal axons and TSCs at nearby endplates within the same focal
plane were clearly labeled. Other possibilities are that SC processes
have not yet reached the terminal or that a small proportion of SCs
undergo apoptosis (cf. Trachtenberg and Thompson, 1996 ).
The results presented here show that junctions gain SCs as they mature.
Initially this gain must be accounted for by migration. Such migration
is not surprising given that it has been shown to be a primary
mechanism accounting for population of developing nerves with SCs
(Peters and Muir, 1959 ; Speidel, 1964 ). Although migration must be
invoked to get the first cells to the junction, mitotic labeling shows
that division of SCs also accounts for the addition. Comparison of the
rate of SC addition to junctions and the extent of mitotic labeling of
TSCs suggests that a considerable amount of this postnatal mitosis
occurs at the junctions. During the first 2 postnatal weeks, TSC number
expands three- to fourfold. The addition of SCs continues at a slower
rate in the adult animal, and this addition appears to be correlated,
in part, with the growth in the size of the endplate. This shows that
whatever mechanisms exist to enlarge the nerve terminal as the muscle
fiber grows may (directly or indirectly) increase the number of SCs to
cover the expanded nerve terminal. However, it is likely that
additional mechanisms determine TSC number, particularly in early
postnatal development during which the largest gain in TSC number
precedes most of the growth in endplate area.
Addition of SCs during repair of muscle innervation
We also investigated the addition of SCs to neuromuscular
junctions during denervation, reinnervation, and nerve sprouting. Denervation alone failed to promote mitosis of TSCs. Our observations are entirely consistent with those of Connor et al. (1987) , who reported that denervation produced mitosis of satellite cells in the
junctional region of frog muscles but did not induce mitosis of TSCs.
However, our results contrast with some reports for mitosis of
nonmyelinating SCs in the nerve. SC mitosis has been reported in
nonmyelinated nerves after injury, although more mitoses are reported
in nerves containing both myelinated and nonmyelinated fibers (Romine
et al., 1976 ; Salzer and Bunge, 1980 ). A recent study has shown that
nonmyelinating SCs in the rat sciatic nerve, which contains both
myelinated and nonmyelinated axons, proliferate to an extent similar to
myelinating SCs during nerve degeneration (Clemence et al., 1988 ). The
reason that TSCs, which are nonmyelinating, would differ from
nonmyelinating SCs in the nerve is unclear.
Although denervation alone does not result in TSC mitosis, it does
appear to provide some stimulus for mitosis considering that TSC
mitosis was not seen in normally innervated adult muscle. Thus, axons
regenerating into denervated muscles stimulate mitosis, and in
partially denervated muscles, some SCs at the remaining innervated
endplates undergo mitosis. In both of these cases, nerves are present,
implying that a nerve-derived factor, in addition to denervated muscle
fibers and/or degenerating nerves, is required. Clear evidence for a
nerve-derived mitogenic signal has been obtained for SC-axon
interactions in vitro (Wood and Bunge, 1975 ; Salzer et al.,
1980a ,b ) and in vivo (Pellegrino and Spencer, 1984 ).
The factor neuregulin has been shown to be a candidate for this axonal signal (Morrissey et al., 1995 ). Other possible neuron-derived SC
mitogens include PDGF, FGF, and calcitonin gene-related peptide (CGRP) (Eccleston, 1992 ; Hokfelt et al., 1994 ; Cheng et al.,
1995 ). Our experiments suggest that reactive TSCs also provide some
kind of stimulus promoting TSC mitosis. Mitoses at innervated synaptic sites in partially denervated muscles were more frequent at sites that
had been contacted by a process extended by a reactive TSC, i.e., an SC
present at a nearby denervated synaptic site. This suggests that a
reactive TSC stimulates division either by direct interaction with the
SC at the innervated synaptic site or indirectly by its promotion of
nerve growth by the nerve terminal. One possible candidate for an
SC-derived mitogenic signal may be TGF- . Schwann cells both
synthesize and possess receptors for TGF- s (Scherer and Salzer,
1996 ). Another possible SC-derived mitogenic signal is neuregulin, a
factor produced and secreted by SCs both in vitro (Raabe et
al., 1996 ) and in vivo (Carroll et al., 1997 ).
In cases of nerve injury, the promotion of TSC mitosis appears to make
functional sense. Division during reinnervation could function to
increase the amount of SC membrane available to cover the reforming
nerve terminal, perhaps compensating for SCs that migrate from the
junctions during the time of denervation or for the SC processes that
extend away from the junction. In partially denervated muscles,
stimulation of SC division may provide additional SC membrane necessary
for the wrapping of nerve sprouts. However, SC process extension does
not require cell division, because TSCs extend long and numerous
processes after denervation (Reynolds and Woolf, 1992 ).
TSCs and synaptic stability
In several cases, TSC division appears to be correlated with
changes in the structure of the neuromuscular synapse. During the first
2 weeks of postnatal development in the rat, synapse elimination
reduces the number of motor neurons innervating each fiber from several
to one. During this period, the SC number increases three- to fourfold
at junctions. As new SCs are generated and take up residence at the
endplate, SC-nerve terminal contact must also be rearranged. An EM
study has shown that during this period, SC processes intervene between
and separate axon terminals (Korneliussen and Jansen, 1976 ). Pomeroy
and Purves (1988) , observing vitally the movements of synaptic
glial cells in mouse parasympathetic ganglia, suggested that these
glial movements were involved in synaptic rearrangements. The
neuregulin glial growth factor, suggested as an axon-derived mitogenic
signal for SCs (Morrissey et al., 1995 ), if applied to developing
neuromuscular junctions induces SC proliferation and decreases synaptic
contacts at neuromuscular junctions (Trachtenberg and Thompson, 1997 ).
Reactive TSC processes contacting innervated endplates in adult muscle
were shown in the present study to cause TSC mitosis; a previous study
has shown that these reactive SCs alter the apposition of nerve
terminal and muscle fibers (Trachtenberg and Thompson, 1997 ). Whether
the changes in synaptic glia are a consequence or a cause of synaptic change awaits further experimentation.
 |
FOOTNOTES |
Received May 28, 1998; revised Aug. 25, 1998; accepted Aug. 28, 1998.
This work was supported by grants from National Institutes of Health
and the National Science Foundation. We thank Ying Lu for advice on the
BrdU protocol, and Harold Zakon, James Larimer, and Jane Lubischer for
critical comments on this manuscript.
Correspondence should be addressed to Flora M. Love, Department of
Zoology, University of Texas at Austin, Austin, TX 78712.
 |
REFERENCES |
-
Asbury AK
(1967)
Schwann cell proliferation in developing mouse sciatic nerve. A radioautographic study.
J Cell Biol
34:735-743[Abstract/Free Full Text].
-
Balice-Gordon RJ,
Lichtman JW
(1990)
In vivo visualization of the growth of presynaptic and postsynaptic elements of neuromuscular junctions in the mouse.
J Neurosci
10:894-908[Abstract].
-
Balice-Gordon RJ,
Breedlove SM,
Bernstein S,
Lichtman JW
(1990)
Neuromuscular junctions shrink and expand as muscle fiber size is manipulated: in vivo observations in the androgen-sensitive bulbocavernosus muscle of mice.
J Neurosci
10:2660-2671[Abstract].
-
Bravo R,
Macdonald-Bravo H
(1987)
Existence of two populations of cyclin/proliferation cell nuclear antigen during the cell cycle: association with DNA replication sites.
J Cell Biol
105:1549-1554[Abstract/Free Full Text].
-
Carroll SL,
Miller ML,
Frohnert PW,
Kim SS,
Corbett JA
(1997)
Expression of neuregulins and their putative receptors, erbB2 and erbB3, is induced during Wallerian degeneration.
J Neurosci
17:1642-1659[Abstract/Free Full Text].
-
Cheng L,
Khan M,
Mudge AW
(1995)
Calcitonin gene-related peptide promotes Schwann cell proliferation.
J Cell Biol
129:789-796[Abstract/Free Full Text].
-
Clemence A,
Mirsky R,
Jessen KR
(1988)
Non-myelin-forming Schwann cells proliferate rapidly during Wallerian degeneration in the rat sciatic nerve.
J Neurocytol
18:185-192.
-
Connor EA,
McMahan UJ,
Marshall RM
(1987)
Cell accumulation in the junctional region of denervated muscle.
J Cell Biol
104:109-120[Abstract/Free Full Text].
-
Dahm LM,
Landmesser LT
(1988)
The regulation of intramuscular nerve branching during normal development and following activity blockade.
Dev Biol
130:621-644[ISI][Medline].
-
Eccleston PA
(1992)
Regulation of Schwann cell proliferation: mechanisms involved in peripheral development.
Exp Cell Res
99:1-9.
-
Georgiou J,
Robitaille R,
Trimble WS,
Charlton MP
(1994)
Synaptic regulation of glial protein expression in vivo.
Neuron
12:443-455[ISI][Medline].
-
Grim M,
Halata Z,
Franz T
(1992)
Schwann cells are not required for guidance of motor nerves in the hindlimb in Splotch mutant mouse embryos.
Anat Embryol
186:311-318[Medline].
-
Harrison R
(1924)
Neuroblast versus sheath cells in the development of peripheral nerves.
J Comp Neurol
37:123-205.
-
Hirata K,
Zhou C,
Nakamura K,
Kawabuchi M
(1997)
Postnatal development of Schwann cells at neuromuscular junctions, with special reference to synapse elimination.
J Neurocytol
26:799-809[ISI][Medline].
-
Hokfelt T,
Zhang X,
Wiesenfeld-Hallin Z
(1994)
Messenger plasticity in primary sensory neurons following axotomy and its functional implications.
Trends Neurosci
17:22-30[ISI][Medline].
-
Jacob M,
Lentz TL
(1979)
Localization of acetylcholine receptors by means of horseradish peroxidase-alpha-bungarotoxin during formation and development of the neuromuscular junction in the chick embryo.
J Cell Biol
82:195-211[Abstract/Free Full Text].
-
Jahromi BS,
Robitaille R,
Charlton MP
(1992)
Transmitter release increases intracellular calcium in perisynaptic Schwann cells in situ.
Neuron
8:1069-1077[ISI][Medline].
-
Johnson GD,
de C Nogueira Araujo GM
(1981)
A simple method of reducing the fading of immunofluorescence during microscopy.
J Immunol Methods
43:349-350[ISI][Medline].
-
Kelly AM,
Zacks SI
(1969)
The fine structure of motor endplate morphogenesis.
J Cell Biol
42:154-169[Abstract/Free Full Text].
-
Keynes RJ
(1987)
Schwann cells during neural development and regeneration: leaders or followers?
Trends Neurosci
10:137-139.
-
Korneliussen H,
Jansen JKS
(1976)
Morphological aspects of the elimination of polyneuronal innervation of skeletal muscle fibres in newborn rats.
J Neurocytol
5:591-604[ISI][Medline].
-
Kullberg RW,
Lentz TL,
Cohen MW
(1977)
Development of the myotomal neuromuscular junction in Xenopus laevis: an electrophysiological and fine-structural study.
Dev Biol
60:101-129[ISI][Medline].
-
Liley AW
(1956)
An investigation of spontaneous activity at the neuromuscular junction of the rat.
J Physiol (Lond)
132:650-666.
-
Love FM,
Thompson WJ
(1996)
Rat neuromuscular junctions gain terminal Schwann cells during postnatal development.
Soc Neurosci Abstr
22:1474.
-
Morrissey TK,
Levi ADO,
Nuijens A,
Sliwkowski MX,
Bunge RP
(1995)
Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2.
Proc Natl Acad Sci USA
92:1431-1435[Abstract/Free Full Text].
-
Noakes PG,
Bennett MR
(1987)
Growth of axons into developing muscles of the chick forelimb is preceded by cells that stain with Schwann cell antibodies.
J Comp Neurol
259:330-347[ISI][Medline].
-
Pellegrino RG,
Spencer PS
(1984)
Schwann cell mitosis in response to regenerating peripheral axons in vivo.
Brain Res
341:16-25.
-
Peters A,
Muir AR
(1959)
The relationship between axons and Schwann cells during development of peripheral nerves in the rat.
J Exp Physiol
44:117-130.
-
Pomeroy SL,
Purves D
(1988)
Neuron/glia relationships observed over intervals of several months in living mice.
J Cell Biol
107:1167-1175[Abstract/Free Full Text].
-
Raabe TD,
Clive DR,
Neuberger TJ,
Wen D,
DeVries GH
(1996)
Cultured neonatal Schwann cells contain and secrete neuregulins.
J Neurosci Res
46:263-270[ISI][Medline].
-
Reithmacher D,
Sonnenberg-Reithmacher E,
Brinkman V,
Yamaai T,
Lewins GR,
Birchmeier C
(1997)
Severe neuropathies in mice with targeted mutations in the ErbB3 receptor.
Nature
389:725-730[Medline].
-
Reynolds ML,
Woolf CJ
(1992)
Terminal Schwann cells elaborate extensive processes following denervation of the motor endplate.
J Neurocytol
21:50-66[ISI][Medline].
-
Robitaille R
(1995)
Purinergic receptors and their activation by endogenous purines at perisynaptic glial cells of the frog neuromuscular junction.
J Neurosci
15:7121-7131[Abstract].
-
Robitaille R,
Jahromi BS,
Charlton MP
(1997)
Muscarinic calcium responses resistant to muscarinic antagonists at perisynaptic Schwann cells of the frog neuromuscular junction.
J Physiol (Lond)
504:337-347[ISI][Medline].
-
Romine JS,
Bray GM,
Aguayo AJ
(1976)
Schwann cell multiplication after crush injury of unmyelinated fibers.
Arch Neurol
33:49-54[Abstract].
-
Salzer JL,
Bunge RP
(1980)
Studies of Schwann cell proliferation: I. An analysis in tissue culture of proliferation during development, Wallerian degeneration and direct injury.
J Cell Biol
84:739-752[Abstract/Free Full Text].
-
Salzer JL,
Bunge RP,
Glazer L
(1980a)
Studies of Schwann cell proliferation: III. Evidence for the surface localization of the neurite mitogen.
J Cell Biol
84:767-778[Abstract/Free Full Text].
-
Salzer JL,
Williams AK,
Glazer L,
Bunge RP
(1980b)
Studies of Schwann cell proliferation: II. An analysis in tissue culture of proliferation during development, Wallerian degeneration and direct injury.
J Cell Biol
84:739-752.
-
Scherer SS,
Salzer JL
(1996)
Axon-Schwann cell interactions during peripheral nerve degeneration and regeneration.
In: Glial cell development (Jessen KR,
Richardson WD,
eds), pp 165-196. Oxford: BIOS.
-
Slater C
(1982)
Postnatal maturation of nerve-muscle junctions in hindlimb muscles of the mouse.
Dev Biol
94:11-22[ISI][Medline].
-
Son Y-J,
Thompson WJ
(1995a)
Schwann cell processes guide regeneration of peripheral axons.
Neuron
14:125-132[ISI][Medline].
-
Son Y-J,
Thompson WJ
(1995b)
Nerve sprouting in muscle is induced and guided by processes extended by Schwann cells.
Neuron
14:133-141[ISI][Medline].
-
Speidel CC
(1964)
In vivo studies of myelinated nerve fibers.
Int Rev Cytol
16:173-231[ISI][Medline].
-
Swartz DJ,
Santi PA
(1996)
Immunofluorescent artifacts due to the pH of anti-fading mounting media.
Biotechniques
20:398-400[ISI][Medline].
-
Thompson WJ,
Jansen JKS
(1977)
The extent of sprouting of remaining motor units in partly denervated immature and adult rat soleus muscle.
Neuroscience
2:523-535[ISI][Medline].
-
Trachtenberg JT,
Thompson WJ
(1996)
Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor.
Nature
379:174-177[Medline].
-
Trachtenberg JT,
Thompson WJ
(1997)
Nerve terminal withdrawal from rat neuromuscular junctions induced by neuregulin and Schwann cells.
J Neurosci
17:6243-6255[Abstract/Free Full Text].
-
Usson Y,
Saxod R
(1988)
Schwann cell proliferation in the sciatic nerve of hypothyroid chick embryos studied by autoradiography and image analysis.
J Neurocytol
17:639-648[ISI][Medline].
-
Waerhaug O
(1992)
Postnatal development of rat motor nerve terminals.
Anat Embryol
185:115-123[Medline].
-
Wood PM,
Bunge RP
(1975)
Evidence that sensory axons are mitogenic for Schwann cells.
Nature
256:662-664[Medline].
-
Yntema CL
(1943)
Deficient efferent innervation of the extremities following removal of neural crest in Amblystoma.
J Exp Zool
94:319-349.
Copyright © 1998 Society for Neuroscience 0270-6474/98/18229376-10$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
C. R. Hayworth, S. E. Moody, L. A. Chodosh, P. Krieg, M. Rimer, and W. J. Thompson
Induction of neuregulin signaling in mouse schwann cells in vivo mimics responses to denervation.
J. Neurosci.,
June 21, 2006;
26(25):
6873 - 6884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Feng, S. Koirala, and C.-P. Ko
Synapse-Glia Interactions at the Vertebrate Neuromuscular Junction
Neuroscientist,
October 1, 2005;
11(5):
503 - 513.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zuo, J. L. Lubischer, H. Kang, L. Tian, M. Mikesh, A. Marks, V. L. Scofield, S. Maika, C. Newman, P. Krieg, et al.
Fluorescent Proteins Expressed in Mouse Transgenic Lines Mark Subsets of Glia, Neurons, Macrophages, and Dendritic Cells for Vital Examination
J. Neurosci.,
December 8, 2004;
24(49):
10999 - 11009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Meins, P. Piosik, N. Schaeren-Wiemers, S. Franzoni, E. Troncoso, J. Z. Kiss, C. Brosamle, M. E. Schwab, Z. Molnar, and D. Monard
Progressive Neuronal and Motor Dysfunction in Mice Overexpressing the Serine Protease Inhibitor Protease Nexin-1 in Postmitotic Neurons
J. Neurosci.,
November 15, 2001;
21(22):
8830 - 8841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Love and W. J. Thompson
Glial Cells Promote Muscle Reinnervation by Responding to Activity-Dependent Postsynaptic Signals
J. Neurosci.,
December 1, 1999;
19(23):
10390 - 10396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Lubischer and W. J. Thompson
Neonatal Partial Denervation Results in Nodal But Not Terminal Sprouting and a Decrease in Efficacy of Remaining Neuromuscular Junctions in Rat Soleus Muscle
J. Neurosci.,
October 15, 1999;
19(20):
8931 - 8944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Lubischer and D. M. Bebinger
Regulation of Terminal Schwann Cell Number at the Adult Neuromuscular Junction
J. Neurosci.,
December 15, 1999;
19(24):
RC46 - RC46.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|